Accelerating DrChrono Prior Authorization for Gastroenterology

Klivira automates DrChrono prior authorization for gastroenterology, ensuring timely approvals for high-volume biologics, complex procedures, and specialty medications critical to GI care.

For revenue cycle directors and prior authorization coordinators in gastroenterology, the manual burden of securing approvals for IBD biologics, advanced imaging, and endoscopic procedures is a significant operational challenge. Integrating a robust prior authorization platform with DrChrono EHR is essential for enhancing efficiency, reducing denials, and improving patient access to critical GI treatments.

DrChrono's Role in Ambulatory Gastroenterology

DrChrono, known for its iPad-first design, is a prevalent EMR in small ambulatory and concierge gastroenterology practices. Its intuitive interface supports streamlined clinical documentation, but managing the high volume of prior authorizations for GI-specific treatments often requires external automation to maintain efficiency and ensure continuity of care.

Key Prior Authorization Triggers in Gastroenterology

IBD biologics (e.g., Humira, Stelara, Skyrizi, Entyvio) and biosimilars
Hepatitis C direct-acting antivirals (e.g., Epclusa, Mavyret)
Advanced imaging (e.g., MRCP, MR enterography, CT enterography)
Endoscopic procedures (e.g., capsule endoscopy, ERCP, EUS)
Specialty drugs for functional GI disorders (e.g., Viberzi, Motegrip)
Non-routine colonoscopy surveillance

Seamless Prior Authorization Workflow within DrChrono for GI

Klivira integrates directly with DrChrono via its robust API and FHIR endpoints, allowing prior authorization requests to be initiated directly from the patient chart or order entry screen. This leverages existing clinical data, such as diagnosis codes (ICD-10), procedure codes (CPT), and medication lists, to pre-populate authorization forms and accelerate submission for GI-specific services, minimizing manual data entry.

Critical Documentation for Gastroenterology Prior Authorizations

Diagnosis confirmation and disease severity assessment (Mayo score, CDAI) for IBD biologics per ACG/AGA guidelines.
Prior conventional therapy trials and biologic experience for IBD step therapy.
TB and hepatitis screening results pre-biologic initiation.
Genotype, fibrosis stage, and prior-treatment history for Hepatitis C DAAs.
Clinical question and prior imaging history for advanced abdominal imaging.
Rome criteria for functional GI disorders and prior conservative therapy trials.

Mitigating Frequent Gastroenterology Prior Authorization Denials

Non-compliance with payer step therapy for IBD biologics, including biosimilar mandates.
Insufficient documentation of disease severity (e.g., missing Mayo score, CDAI).
Gaps in pre-biologic screening documentation (e.g., TB, hepatitis).
Incomplete fibrosis stage or treatment history for Hepatitis C DAAs.
Lack of clinical correlation for advanced imaging requests.
Inadequate prior workup or indication for capsule endoscopy.

Klivira's Intelligent Automation for Gastroenterology Workflows

Klivira’s platform is purpose-built to navigate the unique challenges of GI prior authorization. It incorporates ACG/AGA-guideline-aware step therapy logic for IBD biologics, automates treatment-status classification from DrChrono's medication history, and manages the periodic re-authorization burden inherent in chronic GI conditions. This specialized intelligence reduces manual effort and improves approval rates for DrChrono users.

Enhancing Revenue Cycle for DrChrono GI Practices

For small ambulatory and concierge gastroenterology practices utilizing DrChrono, efficient prior authorization directly impacts revenue integrity and patient satisfaction. By automating the PA process, Klivira helps minimize administrative overhead, accelerate time-to-treatment, and reduce costly denials, allowing GI specialists to focus on patient care rather than paperwork. This is particularly crucial for managing the medical-vs-pharmacy benefit split for biologics, a common workflow constraint in gastroenterology.

Frequently asked questions

How does Klivira handle the periodic re-authorization for IBD biologics in DrChrono?

Klivira establishes a proactive re-authorization workflow, automatically tracking approval expiration dates for chronic IBD biologics. It prompts for necessary documentation updates within DrChrono and initiates new requests well in advance, ensuring continuous coverage for patients and reducing administrative burden on your team.

Can Klivira distinguish between medical and pharmacy benefit for GI biologics when integrating with DrChrono?

Yes, Klivira is designed to route prior authorization requests appropriately based on the administration mode of biologic agents, whether provider-administered (medical benefit) or self-administered (pharmacy benefit). This intelligent routing is critical for managing the complex benefit split often seen with GI biologics and ensuring correct submission.

What specific DrChrono data does Klivira use for GI prior authorizations?

Klivira leverages DrChrono's API and FHIR endpoints to extract key clinical data, including patient demographics, diagnoses (ICD-10), procedure codes (CPT), medication history, lab results (e.g., fibrosis scores, genotype), and clinical notes detailing disease severity (e.g., Mayo score, CDAI) to build comprehensive PA requests.

How does Klivira support step therapy compliance for IBD biologics within DrChrono?

Klivira integrates ACG/AGA-guideline-aware step therapy logic. It analyzes a patient's medication history from DrChrono to determine if prior conventional therapies or biosimilars have been attempted, flagging non-compliance or automatically generating appeals with the necessary documentation to meet payer requirements.

Is Klivira compatible with DrChrono's order sets for GI procedures?

Klivira integrates at the point of order entry within DrChrono. When a PA-triggering GI procedure or medication is ordered, the Klivira application can launch via SMART on FHIR, pre-populating the authorization request with order details and patient context directly from DrChrono, streamlining the submission process.